Brickell buys drug prospect, adds new CMO
BOULDER — Brickell Biotech Inc. (Nasdaq: BBI) has acquired a clinical-stage drug candidate and added a chief medical officer to […]
Source: BizWest
Related Articles
BizWest celebrates 40 years covering business and recognizes 40 iconic leaders who inspired the region’s development.
View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving…
Biotechnology boom
The COVID-19 pandemic — and its seemingly never-ending aftermath — has been a nightmare for commercial landlords of many different…
Brickell Biotech launches brand reset amid positioning pivot
BOULDER — Brickell Biotech Inc. (Nasdaq: BBI), a clinical-stage pharmaceutical company, has launched a new brand, logo and website as…
Hospitals’ next hurdles: Worker shortages, inflation, Medicare gaps
The COVID-19 health care crisis tested hospital staffs’ resourcefulness and stamina in the Boulder Valley, Northern Colorado and across the…
A new Foothills — again
FORT COLLINS — The new owners who want to revitalize midtown Fort Collins’ half-century-old Foothills mall say they envision “a…